Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
93 participants
INTERVENTIONAL
2019-04-17
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The early treatment implemented was 12 hours per week of ESDM versus treatment as usual during 2 years. This was done as an RCT, called IDEA. Children will now be included in IDEA-2 SCOLA, a three year follow up study.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Early Interventions on Neurocognitive Profile of Children With Autism Spectrum Disorder
NCT03254264
Early Intervention in Remote Autism (IPAAD)
NCT04660669
Efficiency of Early Intervention for Autism Spectrum Disorder
NCT02608333
Intelligent Robotic Interactions for Children With Autism Spectrum Disorders
NCT05991791
Integrating the ESDM in ASD Preschools in Israel
NCT03362840
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Investigators hypothesize that children who received ESDM 12 hours per week will have a significant decrease of autism symptoms and will have a better scholastic level 5 years after initial inclusion to IDEA.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental group
Children below the age of 3 in this group received 2 years of ESDM intervention for 12 hours per week, and then treatment as usual for the 3 following years.
What is called "treatment as usual" is what the community can usually offer. That is what the control group in IDEA received.
In IDEA-2, both control and interventional group of IDEA will receive treatment as usual during 3 years.
Treatment as usual comprises of different types of interventions, such as speech pathology therapy, occupational therapy and other types of therapy more or less specific to ASD in the community.
ESDM followed by treatment as usual
The intervention was ESDM, delivered by professionals, one therapist per child, 12 hours per week during 2 years.
Then, they will receive the treatment as usual during 3 years in this current follow-up study.
Precise description of the 2 years ESDM treatment can be found in the published protocol of IDEA.
What is called "treatment as usual" is what the community can usually offer. That is what the control group in IDEA received.
In IDEA-2, both control and interventional group of IDEA will receive treatment as usual during 3 years.
Treatment as usual comprises of different types of interventions, such as speech pathology therapy, occupational therapy and other types of therapy more or less specific to ASD in the community.
All the interventions received by the children will be monitored in IDEA-2. All different treatment approaches will be quantified (type, frequency, intensity and duration).
Control group
Children in this group received treatment as usual delivered in the community for the 2 years of IDEA.
Participants will still receive treatment as usual delivered in the community during IDEA-2, in the 3 years following IDEA.
ESDM followed by treatment as usual
The intervention was ESDM, delivered by professionals, one therapist per child, 12 hours per week during 2 years.
Then, they will receive the treatment as usual during 3 years in this current follow-up study.
Precise description of the 2 years ESDM treatment can be found in the published protocol of IDEA.
What is called "treatment as usual" is what the community can usually offer. That is what the control group in IDEA received.
In IDEA-2, both control and interventional group of IDEA will receive treatment as usual during 3 years.
Treatment as usual comprises of different types of interventions, such as speech pathology therapy, occupational therapy and other types of therapy more or less specific to ASD in the community.
All the interventions received by the children will be monitored in IDEA-2. All different treatment approaches will be quantified (type, frequency, intensity and duration).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ESDM followed by treatment as usual
The intervention was ESDM, delivered by professionals, one therapist per child, 12 hours per week during 2 years.
Then, they will receive the treatment as usual during 3 years in this current follow-up study.
Precise description of the 2 years ESDM treatment can be found in the published protocol of IDEA.
What is called "treatment as usual" is what the community can usually offer. That is what the control group in IDEA received.
In IDEA-2, both control and interventional group of IDEA will receive treatment as usual during 3 years.
Treatment as usual comprises of different types of interventions, such as speech pathology therapy, occupational therapy and other types of therapy more or less specific to ASD in the community.
All the interventions received by the children will be monitored in IDEA-2. All different treatment approaches will be quantified (type, frequency, intensity and duration).
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Requiring less than 40 minutes travel to the assessment center
Exclusion Criteria
* Exclusion from IDEA
39 Months
60 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hôpital le Vinatier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
GEOFFRAY MARIE-MAUDE, PH
Role: PRINCIPAL_INVESTIGATOR
CH LE VINATIER
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hopital Vinatier
Bron, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-A02446-47
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.